Indefinite Delivery Contract SPE2DB22D3501

This indefinite-delivery contract was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp as the prime contractor. The contract provides for the delivery of various pharmaceutical products, medical supplies, and consumables to support the Agency's global supply chain responsibilities. Over 30 delivery orders and a potential value of $999,999,999 have been issued against the contract to date, exercising firm fixed-price and fixed-unit-rate pricing for items like prescription drugs, vaccines, surgical preparations, intravenous solutions and contrast agents. Performance is to occur primarily at the prime contractor's corporate headquarters and distribution facilities in Conshohocken, Pennsylvania, with completion dates ranging from September 2023 through December 2025. No set-aside provisions or subcontracting requirements were identified in the task orders reviewed.

The contract aims to efficiently provide the Defense Logistics Agency with direct vendor delivery of medical commodities and pharmaceuticals to support worldwide logistics functions for the Department of Defense. The various delivery orders issued appear intended to fulfill prescription and over-the-counter medication needs, as well as diagnostic and clinical supply needs, at military treatment facilities and for other government agency customers as part of the Agency's mandate to ensure troops' access to necessary health services and resources. Amerisourcebergen Drug Corp's experience in pharmaceutical distribution aligns well with the scope of products, services and period of performance required by the Agency under this contract vehicle.